Home » Topics » Science » New compound

New compound
RSS

Merck & Co. describes antibiotics active against resistant staphylococci

Sep. 6, 1996

NPC-18521, a high-affinity bradykinin B2 receptor antagonist from Scios

Sep. 6, 1996

NSC-665158: HIV-1 reverse transcriptase inhibitor analogue

Aug. 30, 1996

Merck & Co. reports on L-163689

Aug. 30, 1996

Yamanouchi reveals 5HT3 agonist

Aug. 30, 1996

Endothelin converting enzyme inhibitor revealed by Schering-Plough

Aug. 30, 1996

Lilly's new AMPA antagonist, LY-311446

Aug. 30, 1996

Pfizer reports new class of muscarinic agonists

Aug. 30, 1996

CRM-1.13.1: Nicotinic agonist based on lobeline

Aug. 30, 1996

CGP-25454 tested in healthy volunteers

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...